| Date | Time | Source | Headline | Symbol | Company |
| 11/28/2023 | 8:00AM | PR Newswire (US) | Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:29PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:27PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/21/2023 | 4:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/20/2023 | 6:25AM | IH Market News | Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 2:14PM | Dow Jones News | Trending: Weight Loss Drugs are Big, So Lilly is Building a Factory | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 9:00AM | Dow Jones News | Eli Lilly Plans $2.5 Billion Plant in Germany to Meet Rising Demand | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 8:48AM | Dow Jones News | Point Biopharma Holders Resisting Eli Lilly Tender Offer | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 8:00AM | PR Newswire (US) | Lilly to expand injectable manufacturing capacity with planned $2.5 billion site in Germany | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 7:45AM | IH Market News | Friday’s Wall Street Highlights: Applied Materials, ChargePoint, Amazon, Gap, IBM, and more | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 6:53AM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NYSE:LLY | Eli Lilly and Co |
| 11/17/2023 | 6:45AM | PR Newswire (US) | Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023 | NYSE:LLY | Eli Lilly and Co |
| 11/15/2023 | 4:16PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/15/2023 | 6:51AM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NYSE:LLY | Eli Lilly and Co |
| 11/14/2023 | 4:33PM | PR Newswire (US) | Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma | NYSE:LLY | Eli Lilly and Co |
| 11/14/2023 | 10:00AM | PR Newswire (US) | Lilly to Participate in Evercore ISI HealthCONx Conference | NYSE:LLY | Eli Lilly and Co |
| 11/13/2023 | 4:19PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 11/13/2023 | 7:30AM | GlobeNewswire Inc. | POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights | NYSE:LLY | Eli Lilly and Co |
| 11/10/2023 | 10:14AM | IH Market News | Friday’s Wall Street Highlights: The Trade Desk, Unity, Groupon, Diageo, Plug Power, and more | NYSE:LLY | Eli Lilly and Co |
| 11/09/2023 | 11:14AM | Dow Jones News | Eli Lilly on Pace for Largest Percent Decrease Since November 2022 -- Data Talk | NYSE:LLY | Eli Lilly and Co |
| 11/09/2023 | 7:02AM | IH Market News | Thursday’s Wall Street Highlights: Nvidia, Duolingo, Disney, Virgin Galactic, Applovin, and more | NYSE:LLY | Eli Lilly and Co |
| 11/08/2023 | 5:06PM | Edgar (US Regulatory) | Form SC TO-T/A - Tender offer statement by Third Party: [Amend] | NYSE:LLY | Eli Lilly and Co |
| 11/08/2023 | 4:56PM | PR Newswire (US) | Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma | NYSE:LLY | Eli Lilly and Co |
| 11/08/2023 | 3:00PM | Dow Jones News | Trending: Eli Lilly's Mounjaro Approved for Weight Loss in the U.S. | NYSE:LLY | Eli Lilly and Co |
| 11/08/2023 | 12:22PM | PR Newswire (US) | FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems | NYSE:LLY | Eli Lilly and Co |
| 11/06/2023 | 6:09PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LLY | Eli Lilly and Co |